International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 1

India | Pharmacotherapeutics | Volume 11 Issue 6, June 2022 | Pages: 1369 - 1369


Will Dostarlimab Become the New Rectal Cancer Drug of Choice?

Motupalli Sankeerth Kumar, Ponnaluri Lalitha, Seelam Victor John Wilson

Abstract: Information on a recent clinical trial in the United States on a drug that has been shown to be nearly 100% effective against rectal cancer in the sample population.

Keywords: Dostarlimab, Rectal cancer, new drug of choice



Citation copied to Clipboard!

Rate this Article

5

Characters: 0

Received Comments

No approved comments available.

Rating submitted successfully!


Top